» Articles » PMID: 11427894

Structure of the Histone Deacetylase SIRT2

Overview
Journal Nat Struct Biol
Specialty Cell Biology
Date 2001 Jun 28
PMID 11427894
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

Sir2 is an NAD-dependent histone deacetylase that mediates transcriptional silencing at mating-type loci, telomeres and ribosomal gene clusters, and has a critical role in the determination of life span in yeast and Caenorhabditis elegans. The 1.7 A crystal structure of the 323 amino acid catalytic core of human SIRT2, a homolog of yeast Sir2, reveals an NAD-binding domain, which is a variant of the Rossmann fold, and a smaller domain composed of a helical module and a zinc-binding module. A conserved large groove at the interface of the two domains is the likely site of catalysis based on mutagenesis. Intersecting this large groove, there is a pocket formed by the helical module. The pocket is lined with hydrophobic residues conserved within each of the five Sir2 classes, suggesting that it is a class-specific protein-binding site.

Citing Articles

Molecular Sentinels: Unveiling the Role of Sirtuins in Prostate Cancer Progression.

Chouhan S, Muhammad N, Usmani D, Khan T, Kumar A Int J Mol Sci. 2025; 26(1.

PMID: 39796040 PMC: 11720558. DOI: 10.3390/ijms26010183.


The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric Diseases.

Bonomi R, Riordan W, Gelovani J Cells. 2024; 13(19.

PMID: 39404407 PMC: 11476333. DOI: 10.3390/cells13191644.


Activation and inhibition of sirtuins: From bench to bedside.

Fiorentino F, Fabbrizi E, Mai A, Rotili D Med Res Rev. 2024; 45(2):484-560.

PMID: 39215785 PMC: 11796339. DOI: 10.1002/med.22076.


Rhein targets macrophage SIRT2 to promote adipose tissue thermogenesis in obesity in mice.

Zhou R, Zhu Z, Xu P, Shen L, Wang Z, Xue Y Commun Biol. 2024; 7(1):1003.

PMID: 39152196 PMC: 11329635. DOI: 10.1038/s42003-024-06693-6.


Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective.

Scarano N, Brullo C, Musumeci F, Millo E, Bruzzone S, Schenone S Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794171 PMC: 11123952. DOI: 10.3390/ph17050601.